Inspire Investing, LLC Arcus Biosciences, Inc. Transaction History

Inspire Investing, LLC

  • $959 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023
BUY
$16.97 - $22.03 $6,211 - $8,062
366 Added 2.45%
15,318 $311,000
Q1 2023

Apr 24, 2023
BUY
$15.96 - $23.15 $56,354 - $81,742
3,531 Added 30.92%
14,952 $272,000
Q4 2022

Jan 26, 2023
BUY
$19.7 - $35.71 $69,619 - $126,199
3,534 Added 44.81%
11,421 $0
Q3 2022

Nov 07, 2022
BUY
$23.23 - $30.07 $183,215 - $237,162
7,887 New
7,887 $206,000

Others Institutions Holding RCUS

# of Institutions
200
Shares Held
51.5M
Call Options Held
236K
Put Options Held
141K
View Full List

About Arcus Biosciences, Inc.

RCUS Quotes by TradingView
  • Ticker RCUS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,160,000
  • Market Cap $1.02B
  • Description
  • Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...
More about RCUS
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email